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Abstract
Background: It has been previously demonstrated that a single nucleotide polymorphism (SNP)
in the IL13 promoter region, IL13 -1055T>C (rs1800925), was associated with susceptibility to
severe malaria in Thais. In the present study, fine association mapping for a cytokine gene cluster
including IL4, IL5, and IL13 on chromosome 5q31 was conducted using the same malaria subjects
to refine the region containing a primary variant or a haplotype susceptible to severe malaria.
Methods: A total of 82 SNPs spanning 522 kb of the 5q31 region were analysed in 368 patients
with Plasmodium falciparum malaria (203 mild malaria and 165 severe malaria patients).
Results: Only rs1881457 located in the promoter region of IL13, which is in linkage disequilibrium
with rs1800925 (r2 = 0.73), showed a significant association with severe malaria after adjusting for
multiple testing (P = 0.046 by permutation test). This SNP was in a haplotype block spanning 97 kb
(from rs2069812 to rs2240032). The detected haplotype block contained the RAD50 gene and the
promoter of IL13, but not the other genes.
Conclusion: A haplotype block in which a primary polymorphism associated with severe malaria
is likely to be encoded was identified in Thai malaria patients.
Background
Over the course of the last decade a number of studies
have provided evidence for a linkage between the blood
infection level of Plasmodium falciparum and the human
chromosome 5q31 region in African populations [1-4]. In
addition to malaria, the 5q31 region shows a linkage to
the response against other infectious diseases such as
schistosomiasis [5] and leishmaniasis [6]. The 5q31-33
region contains genes encoding the T helper 2-type
cytokines (the interleukin genes IL3, IL4, IL5, IL9, and
IL13) and other immunologically active genes such as
interferon regulatory factor-1 (IRF1). These genes are
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infection.
In a previous study, three single nucleotide polymor-
phisms (SNPs) in the promoter regions of IL3, IL4, and
IL13 were investigated. Of which, a SNP in the IL13 pro-
moter region, IL13 -1055T>C (rs1800925), was found to
be associated with susceptibility to severe malaria in Thais
[7]. However, a number of candidate genes or polymor-
phisms still remain to be analyzed. In addition, no other
polymorphisms surrounding rs1800925 were analyzed
and thus the possibility that the association of rs1800925
with severe malaria may have resulted from linkage dise-
quilibrium (LD) from other polymorphisms could not be
excluded. The aim of this study is to better define the
genomic region showing the association with severe
malaria on the 5q31 region.
Methods
Subjects
A total of 368 adult patients with P. falciparum malaria
(165 patients with severe P. falciparum malaria and 203
patients with mild malaria) living in northwest Thailand
were enrolled in this study. All patients underwent treat-
ment at the Hospital for Tropical Diseases, Faculty of
Tropical Medicine, Mahidol University. Malarial infection
by P. falciparum was confirmed by a positive blood smear
for the asexual form of P. falciparum. Clinical manifesta-
tions of severe and mild malaria were classified according
to the following definitions and criteria. A patient was
classified as severe malaria when he/she has one or more
of the following signs: high parasitaemia (>100,000 para-
site/ml), hypoglycaemia (glucose <22 nmol/l), severe
anaemia (haematocrit <20% or haemoglobin <7.0 g/dl),
and a serum creatinine level of more than 3.0 mg/dl. In
the present study, patients with cerebral malaria were not
analyzed. Mild malaria was characterized by fever without
other any underlying causes of infections and no manifes-
tations of severe malaria as described above. All individu-
als were 13 years of age or older, and the mean ages of
patients with mild malaria and those with severe malaria
were 25.3 and 23.8, respectively. This study was approved
by the institutional review board of the Faculty of Tropical
Medicine, Mahidol University, and the Research Ethics
Committees of the Faculty of Medicine, The University of
Tokyo, and the Graduate School of Comprehensive
Human Sciences, University of Tsukuba. Informed con-
sent was obtained from all participants.
Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using a QIAamp Blood Kit (Qiagen, Hilden, Ger-
many). A total of 82 SNPs within a 522 kb region on
human chromosome 5q31 were genotyped by using the
DigiTag2 assay [8] or TaqMan assay (Table 1). These SNPs
were selected to capture the LD structure on 5q31 in Asian
populations [9].
Statistical analysis
The allele frequency at each SNP locus was compared
between mild and severe malaria patients using the chi-
square test and a permutation P value was calculated from
100000 permutations. A permutation P value of less than
0.05 was considered to be statistically significant. The
pairwise LD coefficients (r2) between SNPs were calcu-
lated to evaluate the structure of LD on 5q31-33 in 368
Thai malaria patients. The frequencies of haplotypes con-
sisting of rs2069812, rs2299015, rs2299014, rs2243677,
rs2522414, rs2299013, rs2252775, rs2522394,
rs2245460, rs2301713, rs3798135, rs2237060,
rs2074369, rs2240032, rs1881457, and rs1800925 were
estimated only for this haplotype block. All the statistical
analyses were performed by using the Haploview software
version 4.0 [10]. The allelic state for each SNP (i.e., ances-
tral or derived) was inferred based on the genome
sequence of Pan troglodytes (chimpanzee), obtained from
the NCBI BLAST database (Table 1). When the genomic
sequence of chimpanzee was not available, one of Macaca
mulatta (rhesus macaque) was used.
Results
Association test
Eighty-two SNPs including rs1800925 were analysed to
evaluate the association of the 5q31 region with severity
of malaria (Table 1). The permutation P value as well as
the raw P value was calculated for each SNP to avoid any
false positive findings due to multiple testing (Table 1 and
Figure 1A). Only rs1881457 showed a significant associa-
tion with severe malaria (raw P value = 0.002 and permu-
tation P value = 0.046) and no SNPs in the other genes
showed any such association (permutation P value >
0.05). When a derived allele is focused on in association
test, rs1881457-C may be referred to as a protective allele
against severe malaria.
LD structure
In previous study, rs1800925 was found to be associated
with severe malaria [7]. Since rs1881457, showing the
strongest association in the present study, is closely
located to rs1800925, these SNPs may be in LD. In addi-
tion, a number of SNPs near rs1881457 and rs1800925
showed also raw P values of less than 0.05 (Table 1 and
Figure 1), thus suggesting that some, if not all, of these
SNPs are in the same haplotype block. To clarify the struc-
ture of the LD around rs1881457 and rs1800925, r2 values
between the 82 SNPs were calculated. The LD analysis for
the 5q31 region revealed that all the SNPs showing low P
values were in a distinct haplotype block spanning 97 kb
from rs2069812 to rs2240032 (Figure 1B). This block
contained the RAD50 gene and the promoter of IL13, butPage 2 of 6
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SNP rs# Gene Allelic state Frequency of derived allele Association P value
Ancestral Derived Severe malaria Mild malaria Raw Permutation
rs162887 SLC22A4 C T 0.369 0.402 0.381 1.000
rs3792876 SLC22A4 C T 0.234 0.236 0.944 1.000
rs3792878 SLC22A4 G A 0.954 0.932 0.235 0.996
rs3805665 SLC22A4 G A 0.23 0.237 0.823 1.000
rs3805668 SLC22A4 G A 0.229 0.236 0.818 1.000
rs270608 SLC22A4 A G 0.338 0.379 0.328 1.000
rs270607 SLC22A4 C T 0.372 0.397 0.515 1.000
rs2073839 SLC22A4 C T 0.234 0.236 0.950 1.000
rs3828673 SLC22A4 G A 0.234 0.236 0.950 1.000
rs3792885 SLC22A4 A T 0.229 0.236 0.818 1.000
rs272842 SLC22A4 T C 0.348 0.299 0.181 0.985
rs3761659 SLC22A4 C G 0.234 0.236 0.950 1.000
rs3805673 SLC22A4 G A 0.228 0.237 0.771 1.000
rs273915 SLC22A4 G C 0.375 0.397 0.563 1.000
rs272887 SLC22A4 C T 0.372 0.397 0.515 1.000
rs273909 SLC22A4 T C 0.071 0.093 0.307 1.000
rs272879 SLC22A4 G C 0.344 0.297 0.201 0.992
rs272873 SLC22A4 C T 0.167 0.175 0.773 1.000
rs2306772 SLC22A4 G A 0.234 0.236 0.950 1.000
rs272867 C T 0.344 0.298 0.205 0.992
rs3788987 SLC22A5 G A 0.232 0.238 0.843 1.000
rs2631362 SLC22A5 T C 0.365 0.376 0.769 1.000
rs2631359 SLC22A5 G A 0.363 0.379 0.671 1.000
rs4646301 SLC22A5 G A 0.236 0.253 0.614 1.000
rs274571 SLC22A5 T C 0.365 0.379 0.719 1.000
rs2073642 SLC22A5 C T 0.241 0.254 0.707 1.000
rs183898 SLC22A5 G C 0.361 0.381 0.597 1.000
rs4646305 SLC22A5 G A 0.237 0.251 0.678 1.000
rs274559 SLC22A5 C T 0.348 0.299 0.181 0.985
rs274558 SLC22A5 C T 0.353 0.299 0.144 0.965
rs274554 SLC22A5 A G 0.837 0.887 0.059 0.748
rs274553 SLC22A5 G C 0.163 0.113 0.059 0.748
rs274551 SLC22A5 C T 0.161 0.113 0.072 0.804
rs274549 SLC22A5 G T 0.163 0.113 0.059 0.748
rs274547 SLC22A5 T A 0.839 0.887 0.072 0.804
rs2285673 LOC441108 C T 0.227 0.199 0.388 1.000
rs2269822 LOC441108 Cb T 0.282 0.281 1.000 1.000
rs3749834 C T 0.236 0.238 0.929 1.000
rs2070730 IRF1 C T 0.418 0.407 0.765 1.000
rs2070727 IRF1 G T 0.42 0.406 0.725 1.000
rs2070723 IRF1 C T 0.582 0.593 0.765 1.000
rs2070722 IRF1 G T 0.596 0.587 0.823 1.000
rs739718a A G 0.257 0.261 0.903 1.000
rs2069812a IL5 T C 0.241 0.302 0.083 0.848
rs2299015 RAD50 A C 0.111 0.186 0.008 0.193
rs2299014 RAD50 T G 0.074 0.07 0.838 1.000
rs2243677 RAD50 G A 0.887 0.804 0.004 0.107
rs2522414 RAD50 G C 0.887 0.804 0.004 0.107
rs2299013 RAD50 Cc G 0.104 0.186 0.004 0.101
rs2252775 RAD50 A C 0.11 0.186 0.007 0.174
rs2522394 RAD50 A G 0.887 0.804 0.004 0.107
rs2245460 RAD50 A T 0.112 0.189 0.006 0.160
rs2301713 RAD50 T C 0.113 0.186 0.010 0.242
rs3798135 RAD50 G A 0.113 0.186 0.010 0.242
rs2237060 RAD50 A C 0.04 0.055 0.351 1.000
rs2074369 RAD50 C T 0.883 0.804 0.006 0.158
rs2240032 RAD50 C T 0.106 0.183 0.006 0.152Page 3 of 6
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IRF1.
Six frequent haplotypes were observed in the detected
block and two of which, haplotypes 1 and 4, bore
rs1881457-C (Table 2). Both haplotypes showed a
decreased frequency in severe malaria patients in compar-
ison to those with mild malaria, thus suggesting that the
association of rs1881457-C with the protection against
severe malaria was not caused by a specific haplotype.
Discussion
In this study rs1881457 was found to be significantly
associated with severe malaria, and this SNP was included
in a haplotype block encompassing the whole RAD50
gene and the promoter of IL13 (Figure 1). Together with
MRE11 and NBS1, RAD50 forms a conserved multipro-
tein complex, MRE11-RAD50-NBS1 (MRN), which plays
an important role in double-strand break repair, cell cycle
checkpoint control, meiotic recombination, and telomere
maintenance [11-13]. In the immune system, the MRN
complex is involved in B cell-specific immunoglobulin
gene diversification (e.g., Ig class-switch recombination,
somatic hypermutation, and gene conversion) [14,15].
The polymorphisms of RAD50 may therefore influence
the affinity and/or effector functions of antibodies. The
IL13 gene encodes a immunoregulatory cytokine (Th2
cytokine) produced by activated Th2 cells. The Th2
cytokines down-regulate macrophage activity, and inhibit
the production of pro-inflammatory cytokines such as
TNF and IL1. It has been reported that increased concen-
trations of TNF and IL1β in serum are observed in severe
malaria patients [16]. The IL13 promoter polymorphisms
may influence the expression of IL13. Thus, both RAD50
and IL13 seem to be plausible candidate genes associated
with severe malaria.
The genes encoding the Th2 cytokines IL5, IL13, and IL4
are subject to coordinate regulation and are expressed in a
cell lineage-specific manner [17,18]. The expressions are
regulated by a locus control region (LCR) located within a
25 kb region containing the 3' portion of RAD50 [19].
Interestingly, the LCR is included in the haplotype block
associated with severe malaria, raising a possibility that
polymorphisms which influence the LCR activity could
account for the observed association with the severity of
malaria.
Since rs1881457 is located in the promoter region of IL13,
the nucleotide change at this site may affect the binding
ability of some transcription factor. The TFSEARCH
(TFSEARCH: Searching Transcription Factor Binding Sites,
http://www.rwcp.or.jp/papia/) program based on the
TRANSFAC databases [20] was used to examine the possi-
bility. The result indicated no possible binding site of
transcription factor at rs1881457 regardless of alleles
rs1881457 IL13 A C 0.124 0.219 0.002 0.046d
rs1800925 IL13 T C 0.894 0.826 0.014 0.296
rs2066960 IL13 A C 0.628 0.636 0.830 1.000
rs20541a IL13 C T 0.33 0.389 0.115 0.924
rs2070874 IL4 T C 0.273 0.274 0.975 1.000
rs2243270 IL4 G A 0.263 0.266 0.913 1.000
rs2243289 IL4 A G 0.729 0.736 0.825 1.000
rs1468215 KIF3A T A 0.26 0.247 0.725 1.000
rs3798132 KIF3A A G 0.352 0.336 0.685 1.000
rs3798130 KIF3A G A 0.671 0.677 0.882 1.000
rs2299007 KIF3A T C 0.383 0.431 0.219 0.994
rs2237057 KIF3A T C 0.742 0.75 0.818 1.000
rs2299006 KIF3A G C 0.654 0.667 0.738 1.000
rs2299005 KIF3A T C 0.661 0.668 0.836 1.000
rs3798129 KIF3A A T 0.336 0.337 0.975 1.000
rs3756754 KIF3A C T 0.022 0.013 0.366 1.000
rs256871 SEPT8 C T 0.609 0.635 0.490 1.000
rs30534 SEPT8 G A 0.391 0.365 0.490 1.000
rs30533 SEPT8 T C 0.386 0.371 0.686 1.000
rs39588 SEPT8 C G 0.383 0.369 0.717 1.000
rs256875 SEPT8 T C 0.385 0.379 0.888 1.000
rs392916 SEPT8 T A 0.532 0.561 0.459 1.000
rs30527 SEPT8 C T 0.62 0.639 0.620 1.000
rs30524 SEPT8 G T 0.383 0.362 0.573 1.000
rs757537 ANKRD43 T C 0.131 0.157 0.357 1.000
a SNP genotyped by TaqMan assay.
b Allelic state could not be inferred.
c Allelic state inferred based on the sequence of rhesus macaque.
d Permutation P value < 0.05.
Table 1: Allele frequencies and association tests for SNPs in 5q31 cytokine cluster (Continued)Page 4 of 6
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(threshold score = 0.85). Therefore, rs1881457 itself may
not be a primary polymorphism associated with severe
malaria, even though rs1881457 showed the strongest
association observed in this study.
Among IL13 polymorphisms, rs1800925 in the IL13 pro-
moter has been reported to be associated with various dis-
eases [21-24]. This SNP is located within a putative
primate-specific cis-regulatory element [25] and has been
shown to affect the promoter activity of IL13 [25] and
IL13 production [26]. In the present study rs1800925 and
rs1881457 had a high r2 value (r2 = 0.73). Therefore, the
possibility that rs1800925 is a primary SNP and the signif-
icant association of rs1881457 with severe malaria
resulted from LD between these SNPs is not excluded. The
Association P values and LD structure of 82 SNPs on 5q31Figure 1
Association P values and LD structure of 82 SNPs on 5q31. Association P values and LD structure of 82 SNPs on 5q31. 
(A) The raw P value (open circle) and permutation P value (shaded square) for each SNP. (B) Pairwise LD measured by r2 
between 82 SNPs. White, shades of grey, and black squares indicate no LD (r2 = 0), intermediate LD (0 < r2 < 1), and strong 
LD (r2 = 1), respectively.
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Table 2: Estimated haplotype frequencies in malaria patients.
Haplotypea Estimated frequency
Severe malaria Mild malaria
1: CCTGGGCATCAACTCT 0.095 0.163
2: TATACCAGATGATCAC 0.723 0.637
3: CAGACCAGATGATCAC 0.03 0.018
4: TATACCAGATGATCCC 0.025 0.04
5: CATACCAGATGATCAC 0.057 0.045
6: CAGACCAGATGCTCAC 0.038 0.048
aThe haplotype consists of rs2069812, rs2299015, rs2299014, 
rs2243677, rs2522414, rs2299013, rs2252775, rs2522394, rs2245460, 
rs2301713, rs3798135, rs2237060, rs2074369, rs2240032, rs1881457, 
and rs1800925. Only haplotypes with the frequency of more than 
0.02 either in severe malaria or in mild malaria were presented.Page 5 of 6
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Malaria Journal 2009, 8:232 http://www.malariajournal.com/content/8/1/232future functional and association studies for rs1881457,
rs1800925, and other polymorphisms, including those
not analyzed in the present study, may thus help us to bet-
ter understand the genetic susceptibility to severe malaria.
Conclusion
A haplotype block spanning 97 kb encompassing RAD50
gene and IL13 promoter region that was associated with
severity of malaria was identified in a Thai population.
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